# NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock

> **NCT02454348** · PHASE4 · WITHDRAWN · sponsor: **University of Arkansas**

## Conditions studied

- Shock, Septic

## Interventions

- **DRUG:** Vasopressin
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT02454348
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-11-01
- **Primary completion:** 2017-11-27
- **Final completion:** 2017-11-27
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left
- **Last updated:** 2017-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02454348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02454348, "NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02454348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*